Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
blood cancer
Biotech
Aptose exits cancer pact after Hanmi buyout blocks development
Aptose Biosciences has scrapped a deal for a blood cancer drug candidate as part of its pending takeover by Hanmi Pharmaceutical.
Nick Paul Taylor
May 14, 2026 6:35am
Fierce Pharma
FDA delays decision on Orca Bio’s cell therapy for blood cancers
Apr 1, 2026 8:00am
Fierce Pharma
Orca rides $250M funding wave toward cancer cell therapy launch
Jan 9, 2026 11:19am
Merck mulls PV program’s future while Takeda takes victory lap
Dec 8, 2025 4:30pm
Nurix trims staff as trial for lead BTK degrader kicks off
Nov 21, 2025 5:05am
Genmab sheds another clinical ADC from $1.8B ProfoundBio buy
Nov 17, 2025 2:17pm
